Pseudoephedrine Guaifenesin
Links shared publicly online about this topic
US District Court rules in favor of Watson in generic Mucinex patent infringement suit
news-medical.net — “Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.” View full resource at news-medical.net
Most Recently Shared on February 10, 2011 at 9:36 am By:
Medicare News: US District Court rules in favor of Watson in generic Mucinex patent infringement suit: Watson Ph... http://bit.ly/gWM4Pn
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Medicare news via News-Medical.Net
Advertisement
